# Cannabis Compounds Could Reverse Disease Affecting One-Third of Adults > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-compounds-reverse-fatty-liver-disease/ > **Published:** 2026-03-10T17:01:45-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:09:35-04:00 > **Clinical Summary:** Explore how cannabis compounds reverse fatty liver disease and their potential clinical impact on metabolic dysfunction and neuroinflammation. --- ✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchNeurologyCBD Dr. Caplan’s Take “What we’re seeing in the lab with cannabinoid reversal of neuroinflammation is genuinely encouraging, but we need to be careful not to confuse mechanistic promise with clinical readiness. I tell my patients with neuroinflammatory concerns that we have early signals worth monitoring, not yet evidence that justifies changing their treatment, and that distinction matters for responsible prescribing.” Clinical Perspective While preclinical findings on [cannabis compounds](https://cedclinic.com/cannabis-terpene-synergy-entourage-effect/) reversing metabolic dysfunction-associated [fatty liver disease](https://cedclinic.com/cannabinoid-receptor-type-1-antagonist-obesity-steatohepatitis/) (MAFLD) are intriguing, clinicians should recognize that laboratory evidence in animal models or cellular systems often does not translate reliably to human clinical benefit, and the current evidence base remains insufficient to recommend cannabis or its derivatives for MAFLD management. The heterogeneity of [cannabis compounds](https://cedclinic.com/cannabis-terpene-synergy-entourage-effect/), variable bioavailability, potential drug interactions, and the lack of standardized dosing regimens further complicate the translation from bench to bedside. Moreover, MAFLD is multifactorial, involving diet, exercise, metabolic disorders, and genetics, which means that even if a single compound showed efficacy in controlled studies, it would likely represent only one component of a comprehensive treatment strategy. Until well-designed randomized controlled trials in humans establish safety and efficacy with appropriate comparator arms, clinicians should continue counseling patients on proven intervent 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+Cannabis+compounds+could+reverse+disease+affecting+one-third+of+adults+-+Fox+News+%40drcaplan&url=https%3A%2F%2Fwww.foxnews.com%2Fhealth%2Fcannabis-compounds-could-reverse-disease-affecting-one-third-adults)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fwww.foxnews.com%2Fhealth%2Fcannabis-compounds-could-reverse-disease-affecting-one-third-adults)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+Cannabis+compounds+could+reverse+disease+affecting+one-third+of+adults+-+Fox+News+--+via+%40drcaplan.bsky.social+https%3A%2F%2Fwww.foxnews.com%2Fhealth%2Fcannabis-compounds-could-reverse-disease-affecting-one-third-adults)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) Related Articles - [Research claims compounds found in cannabis could reverse disease that affects one-third of adults](https://cedclinic.com/cannabis-compounds-metabolic-dysfunction-research/) - Cannabis compounds could reverse disease affecting one-third of adults – New York Post - [Compounds found in cannabis reduced liver fat in new study | Fox News](https://cedclinic.com/cannabinoids-reduce-hepatic-steatosis-study/) 📰 Source: [https://www.foxnews.com/health/cannabis-compounds-could-reverse-disease-affecting-one-third-adults](https://www.foxnews.com/health/cannabis-compounds-could-reverse-disease-affecting-one-third-adults) CED Clinic Blog[Cannabis compounds could reverse disease affecting one-third of adults – Fox News](https://cedclinic.com/cannabis-compounds-reverse-fatty-liver-disease/) CED Clinic Blog[Cannabis may be beneficial for the brain at an older age | The Jerusalem Post](https://cedclinic.com/cannabis-neuroprotective-benefits-older-adults/) CED Clinic Blog[The Cannabis Mental Health Evidence Gap: Association vs. Causation](https://cedclinic.com/cannabis-mental-health-evidence-gap/) Further Reading Evidence Watch[The Brain Science Behind the Munchies – Nautilus Magazine](https://cedclinic.com/cannabis-appetite-stimulation-neuroscience/) Evidence WatchIGC Pharma Adds Visionary Investigators Network as Clinical Site to Phase 2 CALMA Trial CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Cannabis Compounds May Reverse Fatty Liver Disease, Study Suggests – Science Alert](https://cedclinic.com/cannabinoid-efficacy-nonalcoholic-fatty-liver-disease/) A recent study highlights the potential of cannabis compounds to reverse [fatty liver disease](https://cedclinic.com/cannabinoid-receptor-type-1-antagonist-obesity-steatohepatitis/), offering new insights into [metabolic health](https://cedclinic.com/cannabis-compounds-reverse-fatty-liver-disease/). [Read More](https://cedclinic.com/cannabinoid-efficacy-nonalcoholic-fatty-liver-disease/) [Study Finds Cannabis Compounds May Help Reduce Fatty Liver Disease](https://cedclinic.com/cannabis-compounds-fatty-liver-disease-2026/) This study explores how cannabis compounds may contribute to reducing fatty liver disease, emphasizing the need for further [clinical trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/). [Explore Study](https://cedclinic.com/cannabis-compounds-fatty-liver-disease-2026/) Cannabis May Help Treat Fatty Liver Disease – HepMag.com An article discussing the therapeutic potential of cannabis in treating fatty liver disease and its implications for [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/). Learn More ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).